Chemicals · Founded 1962 · www.jayshreechemicals.com · BSE 506520 · · ISIN INE693E01016
No Notes Added Yet
Business
Jayshree Chemicals Ltd. operates in the chemical sector in India. Typically, a chemical company like Jayshree Chemicals is involved in the manufacturing and distribution of various chemical products. While specific product details are not provided, chemical companies generally produce bulk chemicals, specialty chemicals, intermediates, or a combination thereof, catering to a wide range of industries such as agriculture, textiles, pharmaceuticals, construction, water treatment, and consumer goods. The core business model involves sourcing raw materials, processing them into finished chemical products, and selling them to industrial customers, thereby generating revenue through sales margins.
Revenue Mix
Specific segment breakdown and revenue mix for Jayshree Chemicals Ltd. are not publicly available in this context. However, chemical companies in India typically have segments such as:
Basic/Bulk Chemicals: Large-volume, lower-margin products.
Specialty Chemicals: Higher-value, lower-volume products tailored for specific applications.
Intermediates: Chemicals used as building blocks for other chemical processes.
Without specific data, it's not possible to determine the dominant segment or its contribution to revenue.
Industry
The chemical industry in India is diverse, capital-intensive, and subject to global commodity price fluctuations. It is a foundational industry, supplying inputs to almost all other manufacturing sectors. The industry structure ranges from consolidated in certain bulk chemicals to highly fragmented in specialty chemicals. Jayshree Chemicals operates within this competitive landscape, likely competing on factors such as product quality, price, supply chain reliability, and customer service. Its specific positioning (e.g., niche player, cost leader, technology innovator) would depend on its product portfolio and operational efficiencies within the broader Indian chemical market.
MOAT
Without specific details about Jayshree Chemicals Ltd., potential competitive advantages in the chemical industry can include:
Process Know-how/Technology: Proprietary manufacturing processes leading to cost efficiency or superior product quality.
Scale: Large-scale operations that allow for economies of scale in production and raw material procurement.
Backward/Forward Integration: Control over raw material sourcing or downstream processing, reducing supply chain risks and improving margins.
Strong Customer Relationships: Long-standing ties and customized solutions for key industrial clients.
Regulatory Approvals: Difficult-to-obtain permits or certifications for specific hazardous chemicals or manufacturing processes.
The existence and strength of a durable competitive advantage for Jayshree Chemicals would require a deeper analysis of its operations and market position.
Growth Drivers
Key factors that can drive growth for Jayshree Chemicals Ltd. over the next 3-5 years include:
Domestic Economic Growth: Increased demand from end-user industries (e.g., automotive, construction, agriculture, textiles) driven by India's economic expansion.
"China+1" Strategy: Global supply chain diversification benefiting Indian chemical manufacturers as multinational companies seek alternative sourcing options.
Government Initiatives: Policies like 'Make in India' and Production-Linked Incentive (PLI) schemes promoting domestic manufacturing and chemical sector growth.
Demand for Specialty Chemicals: Growing sophistication of Indian industries driving demand for higher-value, application-specific chemicals.
Infrastructure Development: Increased spending on infrastructure projects requiring various chemical inputs (e.g., paints, coatings, adhesives, construction chemicals).
Risks
Key business risks for Jayshree Chemicals Ltd. include:
Raw Material Price Volatility: Fluctuations in the prices of key inputs (e.g., crude oil, natural gas, basic chemicals) directly impact production costs and profitability.
Environmental and Regulatory Risks: Stringent environmental norms, compliance costs, and potential for operational disruptions due to regulatory changes.
Intense Competition: Competition from both domestic and international players, leading to pricing pressures and margin erosion.
Demand Cyclicality: Dependence on the economic cycles of various end-user industries can lead to volatile demand for chemical products.
Currency Fluctuations: Exposure to foreign exchange rate movements, particularly for imported raw materials or exported products.
Capital Intensity: The chemical industry requires significant capital expenditure for capacity expansion and technological upgrades.
Management & Ownership
Jayshree Chemicals Ltd. is a publicly listed company in India. Like many Indian firms, it is likely promoter-driven, with the founding family or group holding a significant ownership stake and exercising control over strategic decisions. The management team would typically consist of professionals with experience in the chemical industry, responsible for day-to-day operations and executing the company's growth strategy. The remaining ownership is held by institutional investors, high-net-worth individuals, and public shareholders. Specific details on management quality and their track record are not available here.
Outlook
The outlook for Jayshree Chemicals Ltd., operating in the Indian chemical sector, presents a balanced view. On the bullish side, the company stands to benefit from India's robust economic growth, increasing domestic consumption across various industries, and global supply chain realignments ("China+1" strategy) favoring Indian manufacturers. Government support for manufacturing and the growing demand for specialty chemicals also offer significant growth opportunities. However, the company faces inherent challenges. These include the high volatility of raw material prices, stringent environmental regulations, intense competition from both domestic and global players, and the cyclical nature of demand from end-user industries. Navigating these risks while capitalizing on the structural tailwinds will be crucial for sustained performance and profitability.
| #(Fig in Cr.) | Sep 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 3 | 4 | 3 |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income | 2 | 2 | 3 | 2 | 2 | 2 | 3 | 3 | 4 | 4 |
| Total Expenditure | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 3 | 4 | 4 |
| Operating Profit | 0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exceptional Income / Expenses | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| Profit Before Tax | 0 | -0 | -0 | -0 | -0 | -0 | -0 | 0 | 0 | -0 |
| Provision for Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Tax | 0 | -0 | -0 | -0 | -0 | -0 | -0 | 0 | 0 | -0 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | 0 | -0 | -0 | -0 | -0 | -0 | -0 | 0 | 0 | -0 |
| Adjusted Earnings Per Share | 0.1 | -0 | -0.1 | -0 | -0 | -0 | -0 | 0 | 0 | -0.1 |
| #(Fig in Cr.) | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 134 | 122 | 120 | 53 | 1 | 5 | 7 | 2 | 1 | 7 | 9 | 13 |
| Other Income | 15 | 14 | 17 | 12 | 3 | 2 | 2 | 2 | 1 | 1 | 1 | 0 |
| Total Income | 149 | 136 | 137 | 65 | 4 | 6 | 9 | 3 | 2 | 8 | 10 | 14 |
| Total Expenditure | 122 | 128 | 136 | 77 | 3 | 11 | 13 | 5 | 2 | 7 | 10 | 14 |
| Operating Profit | 27 | 9 | 1 | -11 | 2 | -4 | -4 | -2 | 0 | 0 | 0 | 0 |
| Interest | 16 | 20 | 22 | 20 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 9 | 9 | 9 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exceptional Income / Expenses | 0 | -1 | 1 | 55 | -1 | 6 | -0 | 1 | -0 | -1 | -0 | 0 |
| Profit Before Tax | 1 | -22 | -28 | 19 | 1 | 1 | -5 | -1 | -0 | -0 | -0 | 0 |
| Provision for Tax | 1 | -4 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Tax | 1 | -18 | -29 | 19 | 1 | -1 | -5 | -1 | -0 | -0 | -0 | 0 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | 1 | -18 | -29 | 19 | 1 | -1 | -5 | -1 | -0 | -0 | -0 | 0 |
| Adjusted Earnings Per Share | 0.3 | -6.2 | -9.7 | 6.6 | 0.2 | -0.3 | -1.6 | -0.3 | -0.1 | -0.1 | -0.1 | -0.1 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 29% | 65% | 12% | -24% |
| Operating Profit CAGR | 0% | 0% | 0% | -100% |
| PAT CAGR | 0% | 0% | 0% | -100% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | -3% | -7% | -6% | -4% |
| ROE Average | -1% | -2% | -7% | -9% |
| ROCE Average | -1% | -2% | -7% | 2% |
| #(Fig in Cr.) | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Shareholder's Funds | 53 | 35 | 6 | 26 | 23 | 22 | 17 | 16 | 16 | 16 | 14 |
| Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Borrowings | 68 | 51 | 34 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 4 | 1 | 0 | 0 | -2 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Current Liabilities | 73 | 107 | 142 | 14 | 18 | 11 | 9 | 7 | 7 | 7 | 11 |
| Total Liabilities | 198 | 193 | 183 | 40 | 40 | 33 | 27 | 24 | 23 | 23 | 25 |
| Fixed Assets | 154 | 151 | 144 | 5 | 5 | 4 | 4 | 4 | 3 | 3 | 3 |
| Other Non-Current Assets | 11 | 11 | 11 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Total Current Assets | 32 | 30 | 27 | 34 | 34 | 28 | 22 | 19 | 19 | 19 | 21 |
| Total Assets | 198 | 193 | 183 | 40 | 40 | 33 | 27 | 24 | 23 | 23 | 25 |
| #(Fig in Cr.) | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 5 | 2 | 3 | 3 | 5 | 3 | 1 | 3 | 6 | 0 | 4 |
| Cash Flow from Operating Activities | 27 | 13 | 19 | 19 | -1 | -9 | -0 | -1 | 0 | -3 | -2 |
| Cash Flow from Investing Activities | -4 | -5 | -1 | 138 | -1 | 7 | 3 | 4 | -5 | 7 | 1 |
| Cash Flow from Financing Activities | -25 | -6 | -19 | -136 | -0 | -0 | -1 | -0 | -0 | -0 | 0 |
| Net Cash Inflow / Outflow | -3 | 1 | -0 | 21 | -2 | -2 | 2 | 3 | -5 | 4 | -1 |
| Closing Cash & Cash Equivalent | 2 | 3 | 3 | 24 | 3 | 1 | 3 | 6 | 0 | 4 | 3 |
| # | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | 0.29 | -6.17 | -9.73 | 6.63 | 0.22 | -0.28 | -1.6 | -0.33 | -0.08 | -0.12 | -0.07 |
| CEPS(Rs) | 3.42 | -2.95 | -6.82 | 8.08 | 0.32 | -0.17 | -1.49 | -0.24 | 0.01 | -0.03 | 0.02 |
| DPS(Rs) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Book NAV/Share(Rs) | 17.76 | 11.59 | 1.85 | 8.76 | 7.8 | 7.53 | 5.93 | 5.6 | 5.52 | 5.38 | 4.72 |
| Core EBITDA Margin(%) | 7.62 | -4.27 | -11.42 | -39.53 | -165.38 | -124.98 | -84.5 | -187.08 | -217.91 | -10.9 | -11.13 |
| EBIT Margin(%) | 11.73 | -1.49 | -4.41 | 66.37 | 66.96 | 23.21 | -65.85 | -54.33 | -38.01 | -5.05 | -2.2 |
| Pre Tax Margin(%) | 0.98 | -15.84 | -20.98 | 32.82 | 66.26 | 20.06 | -68.29 | -54.76 | -38.12 | -5.05 | -2.25 |
| PAT Margin (%) | 0.56 | -13.2 | -21.15 | 32.74 | 66.26 | -17.19 | -68.29 | -54.76 | -38.12 | -5.05 | -2.25 |
| Cash Profit Margin (%) | 6.65 | -6.32 | -14.81 | 39.86 | 98.99 | -10.38 | -63.85 | -38.93 | 3.53 | -1.25 | 0.57 |
| ROA(%) | 0.42 | -9.25 | -15.18 | 17.48 | 1.58 | -2.24 | -15.56 | -3.84 | -1.01 | -1.47 | -0.84 |
| ROE(%) | 1.63 | -42.05 | -144.91 | 125.05 | 2.6 | -3.64 | -23.75 | -5.76 | -1.45 | -2.12 | -1.36 |
| ROCE(%) | 10.19 | -1.22 | -3.81 | 45.88 | 2.54 | 4.63 | -22.2 | -5.68 | -1.45 | -2.12 | -1.17 |
| Receivable days | 43.06 | 49.86 | 44.31 | 47.54 | 1682.21 | 456.39 | 183.9 | 525.96 | 976.69 | 113.39 | 180.69 |
| Inventory Days | 14.53 | 14.41 | 13.82 | 0 | 1081.11 | 181.6 | 68.46 | 74.2 | 19.2 | 6.18 | 10.05 |
| Payable days | 158.87 | 204.81 | 184.34 | 188.85 | 0 | 273.54 | 102.19 | 322.44 | 2192.19 | 24.84 | 19.1 |
| PER(x) | 27.75 | 0 | 0 | 1.11 | 56.41 | 0 | 0 | 0 | 0 | 0 | 0 |
| Price/Book(x) | 0.45 | 0.45 | 4.04 | 0.84 | 1.56 | 1.59 | 1.22 | 0.51 | 0.59 | 1.2 | 1.16 |
| Dividend Yield(%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EV/Net Sales(x) | 1.03 | 1.19 | 1.33 | -0.04 | 20.26 | 5.98 | 1.74 | -1.5 | 5.59 | 1.2 | 1.09 |
| EV/Core EBITDA(x) | 5.12 | 16.98 | 143.13 | 0.19 | 12.61 | -6.74 | -2.94 | 1.63 | 36.65 | 18.42 | 21.56 |
| Net Sales Growth(%) | 17.66 | -8.68 | -1.34 | -55.8 | -98.21 | 399.38 | 44.14 | -74.11 | -65.06 | 980.96 | 33.34 |
| EBIT Growth(%) | 43.44 | -111.51 | -192.28 | 762.3 | -98.38 | 73.11 | -508.93 | 78.64 | 75.56 | -43.69 | 41.99 |
| PAT Growth(%) | 8.67 | -2247.45 | -57.76 | 168.16 | -96.75 | -229.55 | -472.57 | 79.24 | 75.68 | -43.3 | 40.51 |
| EPS Growth(%) | 8.81 | -2242.49 | -57.77 | 168.18 | -96.75 | -229.58 | -472.57 | 79.24 | 75.68 | -43.37 | 40.54 |
| Debt/Equity(x) | 2.23 | 3.89 | 26.01 | 0 | 0.07 | 0.05 | 0.01 | 0 | 0 | 0 | 0.29 |
| Current Ratio(x) | 0.44 | 0.28 | 0.19 | 2.43 | 1.89 | 2.57 | 2.32 | 2.68 | 2.68 | 2.66 | 1.91 |
| Quick Ratio(x) | 0.36 | 0.24 | 0.15 | 2.43 | 1.73 | 2.39 | 2.25 | 2.67 | 2.68 | 2.63 | 1.88 |
| Interest Cover(x) | 1.09 | -0.1 | -0.27 | 1.98 | 96.48 | 7.37 | -27.01 | -125.97 | -337.14 | -3391 | -38.57 |
| Total Debt/Mcap(x) | 4.97 | 8.67 | 6.44 | 0 | 0.05 | 0.03 | 0.01 | 0.01 | 0 | 0 | 0.25 |
| # | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 46.27 | 46.27 | 46.27 | 46.27 | 46.27 | 46.27 | 46.27 | 46.27 | 46.27 | 46.27 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0.71 | 0.71 | 0.71 | 0.71 | 0.71 | 0.71 | 0.71 | 0.71 | 0.71 | 0.71 |
| Public | 53.02 | 53.02 | 53.02 | 53.02 | 53.02 | 53.02 | 53.02 | 53.02 | 53.02 | 53.02 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 1.36 | 1.36 | 1.36 | 1.36 | 1.36 | 1.36 | 1.36 | 1.36 | 1.36 | 1.36 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 |
| Public | 1.56 | 1.56 | 1.56 | 1.56 | 1.56 | 1.56 | 1.56 | 1.56 | 1.56 | 1.56 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2.93 | 2.93 | 2.93 | 2.93 | 2.93 | 2.93 | 2.93 | 2.93 | 2.93 | 2.93 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | +29% | +65% | +12% | -24% |
| Operating Profit CAGR | — | — | — | -100% |
| PAT CAGR | — | — | — | -100% |
| Share Price CAGR | -3% | -7% | -6% | -4% |
| ROE Average | -1% | -2% | -7% | -9% |
| ROCE Average | -1% | -2% | -7% | +2% |
| # | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 46.27 | 46.27 | 46.27 | 46.27 | 46.27 | 46.27 | 46.27 | 46.27 | 46.27 | 46.27 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0.71 | 0.71 | 0.71 | 0.71 | 0.71 | 0.71 | 0.71 | 0.71 | 0.71 | 0.71 |
| Public | 53.02 | 53.02 | 53.02 | 53.02 | 53.02 | 53.02 | 53.02 | 53.02 | 53.02 | 53.02 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 1.36 | 1.36 | 1.36 | 1.36 | 1.36 | 1.36 | 1.36 | 1.36 | 1.36 | 1.36 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 |
| Public | 1.56 | 1.56 | 1.56 | 1.56 | 1.56 | 1.56 | 1.56 | 1.56 | 1.56 | 1.56 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2.93 | 2.93 | 2.93 | 2.93 | 2.93 | 2.93 | 2.93 | 2.93 | 2.93 | 2.93 |
* The pros and cons are machine generated.
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.
Your relationship manager will connect with you shortly.